APA (7th ed.) Citation

JS, F., VJ, C., J, J., & WJ, C. (2025). Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 10(2), 203. https://doi.org/10.3138/jammi-2024-0025

Chicago Style (17th ed.) Citation

JS, Fung, Cook VJ, Johnston J, and Connors WJ. "Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report." Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'infectiologie Canada 10, no. 2 (2025): 203. https://doi.org/10.3138/jammi-2024-0025.

MLA (9th ed.) Citation

JS, Fung, et al. "Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report." Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'infectiologie Canada, vol. 10, no. 2, 2025, p. 203, https://doi.org/10.3138/jammi-2024-0025.